Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Multiple myeloma]

D Peest1

  • 1Abt. Klinische Immunologie, Medizinische Hochschule Hannover.

Therapeutische Umschau. Revue Therapeutique
|February 1, 1996
PubMed
Summary

Multiple myeloma, a type of non-Hodgkin lymphoma, requires personalized treatment strategies. This review covers diagnostic methods, prognostic factors, and therapeutic approaches for managing this condition.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Therapy of multiple myeloma. What is confirmed?].

Der Internist·2013
Same author

Effects of platelet concentrate storage time reduction in patients after blood stem cell transplantation.

Vox sanguinis·2013
Same author

[Therapy of multiple myeloma: indications and options].

Der Internist·2007
Same author

A new conditioning regimen involving total marrow irradiation, busulfan and cyclophosphamide followed by autologous PBSCT in patients with advanced multiple myeloma.

Bone marrow transplantation·2003
Same author

[Multilocular Castleman's Disease of the mixed type. An rare differential diagnosis in lymphadenopathy with weakness, weight loss and night-sweats].

Deutsche medizinische Wochenschrift (1946)·2001
Same author

The role of alpha-interferon in multiple myeloma.

Pathologie-biologie·1999

Area of Science:

  • Hematology
  • Oncology
  • Internal Medicine

Context:

  • Multiple myeloma is a malignant plasma cell disorder.
  • Current treatment paradigms focus on palliative care.
  • The heterogeneity of the disease necessitates tailored therapeutic plans.

Purpose:

  • To provide a comprehensive overview of diagnostic modalities for multiple myeloma staging.
  • To review key prognostic factors influencing patient outcomes.
  • To discuss various therapeutic strategies and management aspects.

Summary:

  • This review synthesizes current knowledge on diagnosing and staging multiple myeloma.
  • It examines prognostic indicators crucial for treatment individualization.
  • Different therapeutic options and their palliative roles are explored.

Impact:

  • Aids clinicians in developing individualized treatment plans for multiple myeloma patients.
  • Enhances understanding of prognostic factors for better patient stratification.
  • Informs therapeutic decision-making in the palliative care setting for this hematologic malignancy.

Related Experiment Videos